These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7564113)

  • 41. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
    Gao D; Li J; Orosz CG; Bumgardner GL
    Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand.
    Bishop GA; Warren WD; Berton MT
    Eur J Immunol; 1995 May; 25(5):1230-8. PubMed ID: 7539751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells. A redefinition of the TI-2 vs T cell-dependent antigen dichotomy.
    Snapper CM; Kehry MR; Castle BE; Mond JJ
    J Immunol; 1995 Feb; 154(3):1177-87. PubMed ID: 7529792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a costimulatory molecule rapidly induced by CD40L as CD44H.
    Guo Y; Wu Y; Shinde S; Sy MS; Aruffo A; Liu Y
    J Exp Med; 1996 Sep; 184(3):955-61. PubMed ID: 9064355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune reactivity following CD40L blockade: role in autoimmune glomerulonephritis in susceptible recipients.
    Banu N; Zhang Y; Meyers CM
    Autoimmunity; 1999; 30(1):21-33. PubMed ID: 10433091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD40 ligand (CD154) enhances the Th1 and antibody responses to respiratory syncytial virus in the BALB/c mouse.
    Tripp RA; Jones L; Anderson LJ; Brown MP
    J Immunol; 2000 Jun; 164(11):5913-21. PubMed ID: 10820273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cleavable CD40Ig fusion proteins and the binding to sgp39.
    Hollenbaugh D; Douthwright J; McDonald V; Aruffo A
    J Immunol Methods; 1995 Dec; 188(1):1-7. PubMed ID: 8551028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis.
    Hoxha E; Harendza S; Zahner G; Panzer U; Steinmetz O; Fechner K; Helmchen U; Stahl RA
    Nephrol Dial Transplant; 2011 Aug; 26(8):2526-32. PubMed ID: 21633097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD40 cross-linking inhibits specific antibody production by human B cells.
    Callard RE; Herbert J; Smith SH; Armitage RJ; Costelloe KE
    Int Immunol; 1995 Nov; 7(11):1809-15. PubMed ID: 8580079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AUTOIMMUNE DISEASE IN NZB/BL MICE. I. PATHOLOGY AND PATHOGENESIS OF A MODEL SYSTEM OF SPONTANEOUS GLOMERULONEPHRITIS.
    MELLORS RC
    J Exp Med; 1965 Jul; 122(1):25-40. PubMed ID: 14325472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice.
    Resetkova E; Kawai K; Enomoto T; Arreaza G; Togun R; Foy TM; Noelle RJ; Volpé R
    Thyroid; 1996 Aug; 6(4):267-73. PubMed ID: 8875745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course.
    Venkataseshan VS; Lieberman K; Kim DU; Thung SN; Dikman S; D'Agati V; Susin M; Valderrama E; Gauthier B; Prakash A
    Medicine (Baltimore); 1990 Jul; 69(4):200-16. PubMed ID: 2142748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS.
    Green KA; Noelle RJ; Green WR
    Virology; 1998 Feb; 241(2):260-8. PubMed ID: 9499800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides.
    Yellin MJ; D'Agati V; Parkinson G; Han AS; Szema A; Baum D; Estes D; Szabolcs M; Chess L
    Arthritis Rheum; 1997 Jan; 40(1):124-34. PubMed ID: 9008608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential requirements of T cell subsets for CD40 costimulation in immunity to Blastomyces dermatitidis.
    Wüthrich M; Fisette PL; Filutowicz HI; Klein BS
    J Immunol; 2006 May; 176(9):5538-47. PubMed ID: 16622023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.
    Gerritse K; Laman JD; Noelle RJ; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
    Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2499-504. PubMed ID: 8637903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
    Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
    Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens.
    Bruschi M; Carnevali ML; Murtas C; Candiano G; Petretto A; Prunotto M; Gatti R; Argentiero L; Magistroni R; Garibotto G; Scolari F; Ravani P; Gesualdo L; Allegri L; Ghiggeri GM
    J Proteomics; 2011 Sep; 74(10):2008-17. PubMed ID: 21640210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new multivalent B cell activation model--anti-IgD bound to Fc gamma RI: properties and comparison with CD40L-mediated activation.
    Cho S; Conrad DH
    Int Immunol; 1997 Feb; 9(2):239-48. PubMed ID: 9040006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice.
    Holländer GA; Castigli E; Kulbacki R; Su M; Burakoff SJ; Gutierrez-Ramos JC; Geha RS
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4994-8. PubMed ID: 8643517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.